JAK2 and central nervous system cancer: Importantly, SIRT6 overexpression inhibits the activation of the JAK2/STAT3 (Janus kinase 2/signal transducer and activator of transcription 3) signaling pathway, which is often overactive in gliomas, contributing to the anti-cancer effects of SIRT6 [135].